Monte Rosa Therapeutics, Inc. GLUE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$44.5M-195% | -$46.14M— | -$27.08M-13.5% | -$12.3M+59.4% | $46.89M+247% | ||
| $2.03M-0.9% | $2.09M+1.3% | $2.1M-0.4% | $2.13M+3.2% | $2.05M+8.0% | ||
| $5.95M+12.3% | $4.31M-3.6% | $4.36M+1.9% | $4.89M+8.7% | $5.3M+8.7% | ||
| -$37.37M+17.9% | -$43.01M-133% | $100.43M+578% | -$34.72M-25.0% | -$45.49M-19.2% | ||
| $1.87M+17.7% | $767K+319% | $651K+63.2% | $1.7M-16.2% | $1.59M+14.7% | ||
| -$261M-160% | -$65.07M-111% | —— | —— | -$100.23M-1,117% | ||
| $328.34M+2,345,150% | $29.62M+4,772% | $348K+2,220% | $365K-99.6% | $14K-94.3% | ||
| $29.97M+121% | -$78.46M-180% | —— | -$9.03M— | -$145.71M-419% | ||
| -$39.24M+16.7% | -$43.78M-134% | $99.78M+566% | -$36.42M-22.2% | -$47.08M-19.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Monte Rosa Therapeutics, Inc. generate?
- Monte Rosa Therapeutics, Inc. (GLUE) generated -$14.7M in operating cash flow over the trailing twelve months.
- What is Monte Rosa Therapeutics, Inc.'s free cash flow?
- After $5.0M of capital expenditures, Monte Rosa Therapeutics, Inc.'s free cash flow was -$19.7M over the trailing twelve months, down 164.5% year over year.
- Where does Monte Rosa Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Monte Rosa Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
